JESSICA SALAKSANA: Open Payments
NPI 1508549742 · BRENTWOOD, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$249 in 11 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $249
Food & beverage: $249
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $57 |
| SOBI, INC | 1 | $31 |
| ARRAY BIOPHARMA INC | 1 | $26 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $23 |
| Merck Sharp & Dohme LLC | 1 | $22 |
| AstraZeneca Pharmaceuticals LP | 1 | $20 |
| Gilead Sciences, Inc. | 1 | $19 |
| Geron Corporation | 1 | $19 |
| GlaxoSmithKline, LLC. | 1 | $17 |
| Spectrum Pharmaceuticals Inc. | 1 | $16 |
Products named: FRUZAQLA, Vonjo, LORBRENA, Nubeqa, KEYTRUDA, LYNPARZA, Trodelvy, RYTELO.
Industry payments across TN — which companies pay providers there.
